ArticleScientific reports2025
Improving biocide evaluation using propidium monoazide (PMA) viability staining technique.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemical biocides are commonly employed to manage problems caused by microbial processes. In the energy sector, for example, engineered systems are often treated with biocides to control microbiologically influenced corrosion (MIC), biofouling, and the biological generation of hydrogen sulfide. Standard DNA-based methods that are widely used to assess biocide effectiveness often cannot distinguish between live and dead microorganisms, potentially leading to inflated estimates of living cell populations. Incorporating propidium monoazide (PMA) viability staining technique offers a promising solution to this limitation. In this study, we explored the application of PMA within a standard DNA-based workflow to evaluate biocide performance more accurately. A model sulfate-reducing microbial consortium, derived from oilfield produced water, was exposed to widely used biocides including glutaraldehyde (Glut) and tetrakis(hydroxymethyl)phosphonium sulfate (THPS). PMA was applied prior to standard DNA extraction and subsequent qPCR and amplicon sequencing procedures. We observed PMA-derived microbial abundance at least an order of magnitude lower compared to that without PMA. The reduced PMA-derived microbial abundance correlated with the lower ability of the model microbial communities to produce hydrogen sulfide - an association that was absent based on the usual approach without PMA. Biocide-treated communities, in comparison to untreated controls, displayed significant alterations in their microbial ecological properties, such as alpha diversity, beta diversity, and taxonomic composition, as determined through 16S rRNA gene sequencing - differences that were only apparent when PMA was applied. These results confirm that incorporating PMA into standard DNA-based biocide assessment protocols is both feasible and beneficial. Since PMA implementation requires minimal additional effort, we advocate for its adoption in future biocide performance studies, in particular for engineered systems in the energy industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.